Stock Events

Stock Events

Adhera Therapeutics 

$0.9900
2
+$0.00+0%Thursday 14:39

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

Nov 14Expected
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-0.57
-0.38
-0.19
0
Expected EPS
0
Actual EPS
-0.57

Financials

-Profit Margin
Unprofitable
2016
2017
2018
2019
2020
2021
0Revenue
-6.35MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap217.9B
Amgen is a biotech company that develops treatments in areas that may overlap with Adhera's focus on cardiovascular diseases, making them direct competitors in the biopharmaceutical market.
Pfizer
PFE
Mkt Cap158.45B
Pfizer operates in various therapeutic areas, including cardiovascular health, directly competing with Adhera Therapeutics in the pharmaceutical market.
Novartis
NVS
Mkt Cap268B
Novartis is a global healthcare company that offers products in multiple segments, including cardiovascular, competing with Adhera's product offerings.
Merck
MRK
Mkt Cap356.01B
Merck is known for its wide range of pharmaceutical products, including treatments for cardiovascular diseases, positioning it as a competitor to Adhera Therapeutics.
Gilead Sciences
GILD
Mkt Cap179.47B
Gilead Sciences focuses on life-threatening diseases, including cardiovascular conditions, making it a competitor in the same therapeutic area as Adhera.
Abbvie
ABBV
Mkt Cap464.43B
AbbVie operates in various therapeutic areas, including cardiovascular health, competing with Adhera Therapeutics in the biopharmaceutical space.
Bristol-Myers Squibb
BMY
Mkt Cap124.91B
Bristol Myers Squibb offers a range of prescription medicines, including those for cardiovascular diseases, directly competing with Adhera Therapeutics.
Astrazeneca
AZN
Mkt Cap243.34B
AstraZeneca is involved in the discovery, development, and commercialization of prescription medicines, including for cardiovascular diseases, making it a competitor to Adhera.
Johnson & Johnson
JNJ
Mkt Cap617.01B
Johnson & Johnson, through its pharmaceutical segment, develops treatments for various diseases, including cardiovascular, competing with Adhera Therapeutics.
Sanofi
SNY
Mkt Cap95.65B
Sanofi focuses on healthcare solutions, including cardiovascular diseases, positioning it as a competitor in the same market as Adhera Therapeutics.

About

ADHERA THERAPEUTICS INC
Show More
CEO
David A. Battat
Employees
2
Country
United States

Listings

OTC Link
US
ATRX

0 Comments

Share your thoughts

FAQs

What is Adhera Therapeutics stock price today?▼
The current price of ATRXD is $0.99 USD — it has increased by +0% in the past 24 hours. Watch Adhera Therapeutics stock price performance more closely on the chart.
What is Adhera Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTCM exchange Adhera Therapeutics stocks are traded under the ticker ATRXD.
What were Adhera Therapeutics earnings last quarter?▼
ATRXD earnings for the last quarter are -0.27 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Adhera Therapeutics revenue for the last year?▼
Adhera Therapeutics revenue for the last year amounts to 0 USD.
What is Adhera Therapeutics net income for the last year?▼
ATRXD net income for the last year is -6.35M USD.
How many employees does Adhera Therapeutics have?▼
As of October 19, 2026, the company has 2 employees.
In which sector is Adhera Therapeutics located?▼
Adhera Therapeutics operates in the Health & Wellness sector.
When did Adhera Therapeutics complete a stock split?▼
Adhera Therapeutics has not had any recent stock splits.
Where is Adhera Therapeutics headquartered?▼
Adhera Therapeutics is headquartered in Baton Rouge, United States.